Literature DB >> 28681074

Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.

Yin Xi1, Qing Yuan1, Yue Zhang1, Ananth J Madhuranthakam1,2, Michael Fulkerson1, Vitaly Margulis3,4, James Brugarolas4,5, Payal Kapur3,4,6, Jeffrey A Cadeddu3,4, Ivan Pedrosa7,8,9.   

Abstract

OBJECTIVES: To apply a statistical clustering algorithm to combine information from dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) into a single tumour map to distinguish high-grade from low-grade T1b clear cell renal cell carcinoma (ccRCC).
METHODS: This prospective, Institutional Review Board -approved, Health Insurance Portability and Accountability Act -compliant study included 18 patients with solid T1b ccRCC who underwent pre-surgical DCE MRI. After statistical clustering of the parametric maps of the transfer constant between the intravascular and extravascular space (K trans ), rate constant (K ep ) and initial area under the concentration curve (iAUC) with a fuzzy c-means (FCM) algorithm, each tumour was segmented into three regions (low/medium/high active areas). Percentages of each region and tumour size were compared to tumour grade at histopathology. A decision-tree model was constructed to select the best parameter(s) to predict high-grade ccRCC.
RESULTS: Seven high-grade and 11 low-grade T1b ccRCCs were included. High-grade histology was associated with higher percent high active areas (p = 0.0154) and this was the only feature selected by the decision tree model, which had a diagnostic performance of 78% accuracy, 86% sensitivity, 73% specificity, 67% positive predictive value and 89% negative predictive value.
CONCLUSIONS: The FCM integrates multiple DCE-derived parameter maps and identifies tumour regions with unique pharmacokinetic characteristics. Using this approach, a decision tree model using criteria beyond size to predict tumour grade in T1b ccRCCs is proposed. KEY POINTS: • Tumour size did not correlate with tumour grade in T1b ccRCC. • Tumour heterogeneity can be analysed using statistical clustering via DCE-MRI parameters. • High-grade ccRCC has a larger percentage of high active area than low-grade ccRCCs. • A decision-tree model offers a simple way to differentiate high/low-grade ccRCCs.

Entities:  

Keywords:  Clear-cell renal cell carcinoma; Dynamic contrast-enhanced-MRI; Kidney cancer; Statistical clustering; Tumour heterogeneity

Mesh:

Substances:

Year:  2017        PMID: 28681074      PMCID: PMC5718968          DOI: 10.1007/s00330-017-4925-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  42 in total

Review 1.  Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies.

Authors:  James P B O'Connor; Alan Jackson; Geoff J M Parker; Caleb Roberts; Gordon C Jayson
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675

2.  MR classification of renal masses with pathologic correlation.

Authors:  Ivan Pedrosa; Mary T Chou; Long Ngo; Ronaldo H Baroni; Elizabeth M Genega; Laura Galaburda; William C DeWolf; Neil M Rofsky
Journal:  Eur Radiol       Date:  2007-09-26       Impact factor: 5.315

3.  Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images.

Authors:  Weijie Chen; Maryellen L Giger; Hui Li; Ulrich Bick; Gillian M Newstead
Journal:  Magn Reson Med       Date:  2007-09       Impact factor: 4.668

4.  Multifeature analysis of Gd-enhanced MR images of breast lesions.

Authors:  S Sinha; F A Lucas-Quesada; N D DeBruhl; J Sayre; D Farria; D P Gorczyca; L W Bassett
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

5.  Assessing the anatomical characteristics of renal masses has a limited effect on the prediction of pathological outcomes in solid, enhancing, small renal masses: results using the PADUA classification system.

Authors:  Tae Young Shin; Jongchan Kim; Kyo Chul Koo; Sey Kiat Lim; Dong Wook Kim; Min Woong Kang; Koon Ho Rha; Young Deuk Choi; Won Sik Ham
Journal:  BJU Int       Date:  2013-11-27       Impact factor: 5.588

6.  Rising incidence of renal cell cancer in the United States.

Authors:  W H Chow; S S Devesa; J L Warren; J F Fraumeni
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

7.  Treatment management of small renal masses in the 21st century: a paradigm shift.

Authors:  Maxine Sun; Firas Abdollah; Marco Bianchi; Quoc-Dien Trinh; Claudio Jeldres; Rodolphe Thuret; Zhe Tian; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Ann Surg Oncol       Date:  2012-02-10       Impact factor: 5.344

8.  Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma.

Authors:  Patrick E Teloken; R Houston Thompson; Satish K Tickoo; Angel Cronin; Caroline Savage; Victor E Reuter; Paul Russo
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

9.  Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.

Authors:  Mike Notohamiprodjo; Michael Staehler; Nicole Steiner; Felix Schwab; Steven P Sourbron; Henrik J Michaely; Andreas D Helck; Maximilian F Reiser; Konstantin Nikolaou
Journal:  Acad Radiol       Date:  2013-06       Impact factor: 3.173

10.  Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.

Authors:  Hersh Chandarana; Andrew B Rosenkrantz; Thais C Mussi; Sooah Kim; Afshan A Ahmad; Sean D Raj; John McMenamy; Jonathan Melamed; James S Babb; Berthold Kiefer; Atilla P Kiraly
Journal:  Radiology       Date:  2012-12       Impact factor: 11.105

View more
  2 in total

Review 1.  Quantitative Methods in Abdominal MRI: Perfusion Imaging.

Authors:  Ananth J Madhuranthakam; Qing Yuan; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2017-12

2.  Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience.

Authors:  Durgesh K Dwivedi; Yin Xi; Payal Kapur; Ananth J Madhuranthakam; Matthew A Lewis; Durga Udayakumar; Robert Rasmussen; Qing Yuan; Aditya Bagrodia; Vitaly Margulis; Michael Fulkerson; James Brugarolas; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  Clin Genitourin Cancer       Date:  2020-05-23       Impact factor: 2.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.